A major milestone in advancing growth-accommodating, autologous valve reconstruction for pediatric patients.

Our technology enables accurate trileaflet valve reconstruction using autologous pericardium, reducing the need for reoperations and improving long-term outcomes for pediatric patients.
The event, held on the Stanford University campus, brought together leading innovators in pediatric healthcare. Key highlights included:
• AI in Pediatric Start-Ups: Insights from industry leaders on pitfalls and best practices in AI-driven pediatric innovation.
• Innovation and Equity: Dr. Ndidi Unaka emphasized the importance of inclusive innovation practices.
• Closing the Digital Health Gap: Panels discussed collaborative strategies to improve access to digital resources for all children and families.
Being recognized among such groundbreaking projects is an honor that reinforces our commitment to advancing pediatric cardiac care.
This is just the beginning, exciting advancements lie ahead for AVaTAR MedTech.